Is RKLB a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Rocket Lab (RKLB) rests on Neutron medium-lift rocket: Neutron is Rocket Lab's reusable medium-lift vehicle aimed at constellation deployment and larger payloads, the segment SpaceX leads. The bear case rests on rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders. Analysts covering it publish targets from $64.00 to $150.00 against a $50.84 price, so even the professionals disagree by 84% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Rocket Lab (RKLB) is a space company that builds rockets and spacecraft and provides end-to-end space services. Its established business is the Electron, a small orbital launch vehicle that is one of the most frequently flown small rockets in the world, carrying satellites for commercial, government, and defense customers. Rocket Lab is developing Neutron, a larger, partly reusable medium-lift rocket intended to compete for bigger payloads and constellation deployments, directly targeting the market SpaceX dominates. Beyond launch, Rocket Lab has built a sizable Space Systems business: it designs and manufactures satellites, spacecraft components, solar cells, reaction wheels, separation systems, and flight software, and increasingly works as a prime contractor building entire satellites for customers. This makes a large share of revenue come from components and spacecraft rather than launch alone. Founded in 2006 and headquartered in Long Beach, California, with operations in New Zealand, Rocket Lab is one of the few vertically integrated, publicly traded launch-plus-systems players. The operating numbers kept improving through mid-2026. Q2 2026 revenue was about $234 million, up about 62% year over year, with Space Systems contributing about $189.5 million; non-GAAP gross margin rose to about 41.5% from 36.9%, and the adjusted EBITDA loss narrowed to about $8.8 million. Backlog reached a record of about $2.36 billion, up about 137%, helped by an $816 million Space Development Agency award, and Rocket Lab guided Q3 revenue to $250 million to $265 million. It raised about $1.53 billion through stock sales in the first half of 2026, leaving roughly $2.3 billion of cash against about $134 million of debt. On October 16, 2026, however, CEO Peter Beck said Neutron's first launch would slip into 2027 after voids were found in the carbon-composite forward propellant dome, with replacement and testing running through Q1 2027. Several analysts cut price targets (Citizens and TD Cowen to $90), and the stock closed near $52, down about 25% over three months and about 32% year to date. Q3 2026 results are scheduled for November 9.
The bull case: what would have to be true for $150.00
The most optimistic published target on RKLB is $150.00, +195.0% from the $50.84 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Neutron medium-lift rocket.
Neutron is Rocket Lab's reusable medium-lift vehicle aimed at constellation deployment and larger payloads, the segment SpaceX leads. A successful Neutron debut would multiply Rocket Lab's addressable launch market and let it bid for national-security and commercial constellation contracts that Electron cannot serve. The first launch has now slipped into 2027: in October 2026 management cited voids in the carbon-composite forward propellant dome, with replacement and testing through Q1 2027, and analysts say the bigger effect is on launch revenue in 2027 and 2028.
2. Space Systems growth.
The components and spacecraft business, including satellites, solar cells, reaction wheels, and full satellite builds, generates the majority of revenue (about $189.5 million of the roughly $234 million in Q2 2026) and is less binary than launch. Acting as a prime contractor on entire spacecraft moves Rocket Lab up the value chain into higher-dollar, recurring program work, as the $816 million Space Development Agency award shows.
3. Electron launch cadence.
Electron is among the most-flown small launch vehicles globally, giving Rocket Lab a proven, repeatable revenue stream and dedicated small-satellite niche. A steady manifest of commercial, civil, and defense missions underpins the business while Neutron is developed.
4. Defense and national security.
Growing US and allied defense spending on responsive, resilient space access positions Rocket Lab to win launch and satellite contracts. Its vertical integration and US manufacturing footprint make it a credible second source to SpaceX for government programs.
The bear case: what would have to be true for $64.00
The most pessimistic published target is $64.00, +25.9% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Rocket Lab is worth if the risks below bite instead of the drivers above.
Rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders. Neutron faces significant technical, schedule, and ramp risk, and the October 2026 delay of its first launch into 2027 is the latest example; further slips would weigh on the stock, which trades largely on that future option. The launch market is dominated by SpaceX's scale and cost advantages, and competition in small launch and satellite components is intense. Mission failures, supply-chain issues, and lumpy, contract-driven revenue add volatility. At about 43x trailing sales even after a roughly 32% fall in 2026, Rocket Lab remains sensitive to sentiment, funding conditions, and milestone execution rather than steady fundamentals.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding RKLB already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on RKLB
18 analysts cover RKLB, with an average target of $102.94 (+102.5% against $50.84) and a split of 16 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the RKLB forecast and price target page.
How is RKLB valued? (as of October 2026)
Snapshot for RKLB as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$769 million, up ~62% year over year in Q2 2026
- Backlog: ~$2.36 billion record (end Q2 2026)
- Gross margin: ~37% GAAP TTM; ~41.5% non-GAAP in Q2 2026
- Operating margin (TTM): ~-25%
- Net loss (TTM): ~-$165 million (Q2 2026 EPS -$0.08, in line)
- Cash / debt: ~$2.3 billion / ~$134 million
- Price to sales: ~43x trailing
- Market cap / dividend: ~$33 billion (stock ~$52, Oct 16, 2026) / none
Rocket Lab trades as a high-growth space name valued on its Space Systems revenue, backlog and the future option value of Neutron rather than current profits; forward P/E is not meaningful with expected EPS near zero. Even after falling from a 52-week high of $151 to about $52, the stock sits near 43x trailing sales, so the October 2026 Neutron delay and the November 9 Q3 report (consensus revenue about $257 million) matter more to valuation than near-term earnings.
How do you decide if RKLB is a buy?
Rather than asking whether RKLB is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold RKLB indirectly through an index or sector ETF before adding more.
What would change your mind on RKLB
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Neutron medium-lift rocket stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the RKLB stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about RKLB against your real portfolio and see your actual exposure before deciding.
Investing in Rocket Lab with AI
Connect the broker you already use and ask Walnut's AI how RKLB fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is RKLB a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Neutron medium-lift rocket, with revenue (ttm) at ~$769 million, up ~62% year over year in Q2 2026. The bear case rests on rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders. Analysts covering it are spread from $64.00 to $150.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell RKLB?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $64.00, +25.9% from the $50.84 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for RKLB?
+
Neutron medium-lift rocket. Neutron is Rocket Lab's reusable medium-lift vehicle aimed at constellation deployment and larger payloads, the segment SpaceX leads. The most optimistic analyst target on RKLB is $150.00, +195.0% from the $50.84 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for RKLB?
+
Rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders. Neutron faces significant technical, schedule, and ramp risk, and the October 2026 delay of its first launch into 2027 is the latest example; further slips would weigh on the stock, which trades largely on that future option. The launch market is dominated by SpaceX's scale and cost advantages, and competition in small launch and satellite components is intense. Mission failures, supply-chain issues, and lumpy, contract-driven revenue add volatility. At about 43x trailing sales even after a roughly 32% fall in 2026, Rocket Lab remains sensitive to sentiment, funding conditions, and milestone execution rather than steady fundamentals. The most pessimistic published target is $64.00, +25.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Rocket Lab do?
+
Vertically integrated space company: Electron launches, satellites, and the Neutron rocket; a space-economy and defense bet.
What would have to change for RKLB to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Neutron medium-lift rocket) stalling in the reported numbers rather than in the narrative, the risk above (rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What is RKLB's ticker symbol?
+
RKLB, listed on Nasdaq. Officially Rocket Lab USA, Inc. Founded 2006, headquartered in Long Beach, California, with launch operations in New Zealand. Publicly traded since 2021. It trades during US market hours and is available at every major US brokerage.
What does Rocket Lab do?
+
Rocket Lab builds rockets and spacecraft and provides space services. It operates the Electron small launch vehicle, is developing the larger reusable Neutron rocket, and runs a Space Systems business that designs and manufactures satellites, components, solar cells, and flight software, increasingly as a prime contractor on full spacecraft.
Who are Rocket Lab's main competitors?
+
By segment. Orbital launch: SpaceX is the dominant force, with Firefly, ULA, Arianespace, and launch startups also competing. Satellites and spacecraft: Lockheed Martin, Northrop Grumman, L3Harris, and newer satellite makers. Components: specialized space-supply-chain suppliers across solar cells, reaction wheels, and avionics.
Walnut is informational, not investment advice, and gives no verdict on RKLB. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature RKLB
RKLB is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.